|
SLDB Solid Biosciences Inc 1707502 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-54,799,000.00 |
| Balance Sheet |
|
Current Assets
|
$395,108,000.00 |
|
Assets
|
$420,580,000.00 |
|
Current Liabilities
|
$28,584,000.00 |
|
Liabilities
|
$46,505,000.00 |
|
Equity
|
$374,075,000.00 |
|
Shares Out
|
105125366.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-99,817,000.00 |
|
Investing Cash Flow
|
$-88,831,000.00 |
| Market Analysis |
Market Cap
|
$956,640,830.60 |
|
Price
|
$9.10 |
|
BVPS
|
3.56 |
|
PB
|
2.56 |
|
EPS
|
-0.38 |
|
FCF
|
$-100,132,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:27 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
-0.53 |
|
|
2026-05-12 |
-0.52 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.42 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-03 |
-0.48 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLDB documents filed with the SEC.
SLDB Filings
Clear
